Skip to content

Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination

The Impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination Among University Students: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05175482
Enrollment
127
Registered
2022-01-03
Start date
2021-12-30
Completion date
2022-09-30
Last updated
2022-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behavior, Human Papilloma Virus

Brief summary

To evaluate impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination among University Students

Detailed description

In this randomized controlled study, it aims to evaluate impact of Health Belief Model based virtual education on Human Papilloma Virus Infection and Vaccination among University Students.

Interventions

health belief model based virtual education

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* University students aged 18 years or over

Exclusion criteria

* University students have been received HPV vaccine

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline assessment of knowledge level on Human Papilloma Virus (HPV) Infection and Vaccination at first daybaseline and next day after the education (at first day)The scale consists of 10 items. A higher score represents a higher knowledge level.
Change from baseline score of Human Papilloma Virus (HPV) Infection and Vaccination Health Belief Model Scale at first daybaseline and next day after the education (at first day)The scale consists of 14 items. The construction of the scale consists of perceived severity (n=4 items), perceived susceptibility (n=2 items), perceived benefit (n=3 items), perceived barriers (n=5 items). A 4-point Likert scale was used to assess each item.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026